XML 31 R16.htm IDEA: XBRL DOCUMENT v3.20.1
Shareholders' Equity
3 Months Ended
Mar. 27, 2020
Stockholders Equity Note [Abstract]  
Shareholders' Equity

9. Shareholders’ Equity

Stock Appreciation Rights (“SARs”)

As of March 27, 2020, the Company had 2.9 million SARs outstanding with an exercise price of $4.00 per share and an expiration date of February 2022.           

Treasury Stock

Under the Company’s share repurchase plan, the Company may repurchase shares of its outstanding common stock either on the open market or through privately negotiated transactions subject to market conditions and trading restrictions. During the three months ended March 27, 2020, the Company repurchased 73 thousand shares of its common stock at an average price of $13.79 per share for a total cost of $1.0 million.  As of March 27, 2020 the Company had a total authorization remaining of $5.6 million under its repurchase plan with a  total authorization of $147.2 million.    

During the quarter ended March 29, 2019, the Company repurchased 101 thousand shares of its common stock at an average price of $15.99 per share for a total cost of $1.6 million.  

The shares repurchased under the share repurchase plan during the quarter ended March 27, 2020, do not include 125 thousand shares which the Company bought back to satisfy employee net vesting obligations for a cost of $2.0 million. During the quarter ended March 29, 2019, the Company bought back 123 thousand shares at a cost of $2.4 million to satisfy employee net vesting obligations.       

Dividend Program

In 2019, the Company increased the annual dividend from $0.34 per share to $0.36 per share to be paid on a semi-annual basis. During the first quarter of 2020, the Company paid its second semi-annual dividend payment to shareholders, which was declared in 2019 of $5.8 million.  In addition, during the quarter ended March 27, 2020, the Company increased its annual dividend to $0.38 per share to be paid on a semi-annual basis.  These dividends were paid from U.S. domestic sources and are accounted for as an increase to accumulated deficit. The Company’s Board of Directors has deferred the Company’s regular bi-annual dividend declaration decision until closer to the end of the second quarter.  The Board of Directors will consider all relevant information available to us at that time before making a decision.  At this time, the Company cannot predict whether or not it will declare the bi-annual dividend, reduce the dividend, defer the decision further or suspend the dividend program for the rest of the year or longer.